- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04084600
Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer Survivors
The Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer Survivors: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be a double-blind randomized controlled trial, parallel in two groups (intervention group and sham). Participants will initially be evaluated by a trained investigator who will be blinded and assigned randomly (random numbers generated on the computer) block for the intervention and sham groups by an opaque envelope draw. Participants will be randomized into two groups: intervention and sham. Both groups will undergo a kinesiotherapy program once a week for 6 consecutive weeks.
Also, participants in the intervention group will receive, once a week, a manual therapy protocol, while participants in the Sham group will receive traditional massage. When making the invitation to participate in the survey, individuals will not be required to participate if they do not agree, and therefore will not be penalized. Participants who agree to participate in the survey will sign a Free and Informed Consent Form and will be informed of the possibility of withdrawing from the survey at any stage, without penalty. The collection of the evaluation and intervention will be carried out in a salon Clinic School of Physiotherapy in the Center of Health and Sports Sciences (CEFID) of the State University of Santa Catarina (UDESC) in the city of Florianópolis- SC. All personal identification data of the participants will be preserved according to resolution of the national health council, taking into account the possibility of scientific dissemination of the results obtained. The risks of these procedures will be medium, since the participant may present muscle pain after the intervention protocol. To minimize these risks will be available, if necessary, attendance at the Clinic School of Physiotherapy. The sample will be selected in a non-probabilistic way for convenience. This study will include women diagnosed with breast cancer who have undergone breast surgery with curative intent and who have completed chemotherapy and / or radiotherapy treatments.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Santa Catarina
-
Florianópolis, Santa Catarina, Brazil, 88080350
- Santa Catarina State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age over 18 years;
- have had surgery to treat breast cancer;- have completed chemotherapy and / or radiotherapy;
- have upper quadrant pain homolateral to surgery for at least the last 3 months, with a score of 4 or more on the visual analog scale (VAS) in the last week
- present a score greater than or equal to 30 on the Arm, Shoulder, and Hand Dysfunction Questionnaire (DASH).
Exclusion Criteria:
- difficulty in understanding the Portuguese language to answer the questionnaires;
- have had bilateral surgery to treat breast cancer;
- be in palliative care;
- pregnant women;
- be using analgesic and / or anti-inflammatory drugs
- women with rheumatic diseases
- be in physical therapy during the intervention period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group
Once a week for 6 consecutive weeks, this group will receive a manual therapy protocol with an approach based on Taylor et al., 1990; Schleip et al., 2012; Bienfait, 1999 and Myers, 2016, lasting 20 minutes, focused on the upper quadrant homolateral to the surgery.
Shortly thereafter, this group will participate in a kinesiotherapy protocol with stretching, mobility and strengthening exercises, also for 20 minutes.
All sessions will be individual.
|
Kinesiotherapy Protocol is an specific exercise based treatment designed to strengthening, gaining range of motion and stretching the muscles.
Manual therapy protocol: is a manual treatment intended to the release of fascias and soft tissues.
|
SHAM_COMPARATOR: Sham Group
Once a week for 6 consecutive weeks, this group will receive a soft and shallow traditional massage, lasting 20 minutes.
Shortly thereafter, this group will participate to the same kinesiotherapy protocol with stretching, mobility and strengthening exercises, also for 20 minutes.
All sessions will be individual.
|
Kinesiotherapy Protocol is an specific exercise based treatment designed to strengthening, gaining range of motion and stretching the muscles.
Traditional Massage is a gentle and superficial massage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Chronic Pain Intensity
Time Frame: Change from Pre Intervention Chronic Pain Intensity at 6 weeks Post Intervention
|
Chronic pain intensity will be evaluated through the analogue visual scale.
It consists of a numbered line from 1 to 10, 0 being no pain and 10 the worst pain imaginable.
|
Change from Pre Intervention Chronic Pain Intensity at 6 weeks Post Intervention
|
Change in Pain Location
Time Frame: Change from Pre Intervention Pain Location at 6 weeks Post Intervention
|
Pain location will be assessed using a Body Pain Diagram.
It is a graphical representation of a woman's body in anterior, posterior, and lateral views to identify the location and frequency of pain.
In this diagram, women should mark with a X their main pain points in the upper quadrant homolateral to the surgery.
|
Change from Pre Intervention Pain Location at 6 weeks Post Intervention
|
Change in Neuropathic Pain
Time Frame: Change from Pre Intervention neuropathic pain at 6 weeks Post Intervention
|
Neuropathic Pain will be assessed using the Douler Neuropathique 4 Questionnaire.
It aims to discriminate neuropathic pain from nociceptive pain.
It consists of 10 items grouped into 4 sections.
The first 7 items are related to pain quality (burning, painful cold, and electric shock) and its association with abnormal sensations (tingling, numbness, and itching).
The remaining 3 items are associated with neurological examination in the painful area (touch hypoesthesia, needle stick hypoesthesia, and tactile allodynia).
Each positive item receives a 1-point score and the total score is calculated as the sum of all 10 items.
A score of 4 or higher indicates the diagnosis of neuropathic pain.
|
Change from Pre Intervention neuropathic pain at 6 weeks Post Intervention
|
Change in central sensitization pain
Time Frame: Change from Pre Intervention central sensitization pain at 6 weeks Post Intervention
|
Central sensitization pain will be assessed using the the Central Sensitization Questionnaire.
It aims to evaluate the symptoms considered associated with central sensitization pain.
The total score ranges from 0 to 100 and a score of 40 or more indicates the presence of central sensitization pain.
|
Change from Pre Intervention central sensitization pain at 6 weeks Post Intervention
|
Change in pain dimensions
Time Frame: Change from Pre Intervention pain dimensions at 6 weeks Post Intervention
|
Pain dimensions will be assessed using the McGill Pain Questionnaire.
It is an instrument that assesses pain dimensions in physical (sensitive and discriminative) aspects, pain interpretation (affective and motivational) and pain understanding (cognitive and evaluative).
It is made up of 4 large groups, divided into 20 smaller groups of words, each of which is related to a type of pain.
The groups are numbered according to intensity, with 1 being the smallest: 10 groups of 42 words related to physical aspects; 5 groups of 14 words related to the affective part; 1 group of 5 words about pain in general; 4 groups of 17 words that did not fit the other groups, called miscellaneous.
The values are summed and the result is given by the pain index (sum of the intensity values of the chosen descriptors, with a maximum value of 78) and by the number of descriptors (how many words were marked, with a maximum value of 20).
|
Change from Pre Intervention pain dimensions at 6 weeks Post Intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Upper limb functionality
Time Frame: Change from Pre Intervention Upper limb functionality at 6 weeks Post Intervention
|
The Arm, Shoulder and Hand Dysfunctions Questionnaire (DASH) will be used to assess disabilities and physical symptoms of the upper limbs.
It is a 30-item questionnaire that evaluates the physical disabilities and symptoms of upper limbs in a wide variety of musculoskeletal disorders.
The Likert score ranges from 1 to 5 and the total score ranges from 0 to 100, where higher scores represent higher physical disabilities and upper limb symptoms.
The questions refer to the last week and the questionnaire items are divided into physical function, symptoms and social function.Questionnaire.
|
Change from Pre Intervention Upper limb functionality at 6 weeks Post Intervention
|
Muscle strength
Time Frame: Change from Pre Intervention Muscle strength at 6 weeks Post Intervention
|
Muscle strength will be assessed by the Kendall scale, graded from 1 to 5.
|
Change from Pre Intervention Muscle strength at 6 weeks Post Intervention
|
Range of motion
Time Frame: Change from Pre Intervention Range of motion at 6 weeks Post Intervention
|
The range of motion will be evaluated by a goniometer
|
Change from Pre Intervention Range of motion at 6 weeks Post Intervention
|
Circumference of the arm
Time Frame: Change from Pre Intervention Circumference of the arm at 6 weeks Post Intervention
|
The circumference of the arm will be evaluated by the perimeter.
|
Change from Pre Intervention Circumference of the arm at 6 weeks Post Intervention
|
Collaborators and Investigators
Investigators
- Study Chair: Gilmar M Santos, PhD, Universidade do Estado de Santa Catarina this account disabled
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Manual Therapy BCS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
Clinical Trials on Kinesiotherapy Protocol
-
University of the State of Santa CatarinaRecruiting
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Federal University of São PauloCompleted
-
University of RzeszowRecruitingCervical Spine SyndromePoland
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Fundação de Apoio ao...RecruitingUpper Limb; Injury, Superficial, MultipleBrazil
-
University of Sao Paulo General HospitalUnknownUrinary Stress IncontinenceBrazil
-
University of Campinas, BrazilCompletedBreast Cancer | Axillary Lymph Node Dissection | Shoulder Joint LimitationBrazil
-
Federal University of São PauloCompleted
-
Universidade do Vale do ParaíbaUnknownMuscle Weakness ConditionsBrazil
-
Jolanta ZwolińskaCompleted